Cambridge, MA (PRWEB) June 06, 2012
Cambridge Healthtech Institute (CHI) of Needham, MA, today announced a strategic alliance with the Consumer Genetics Council and its principals, John Boyce, President & CEO of GnuBIO, and Principal of Delphi Bio, and Meredith Salisbury, senior consultant with Bioscribe. Through this partnership, Boyce and Salisbury will serve as senior advisors with CHI directing the organizational, promotional and operational details for the annual Consumer Genetics Conference, which will convene again in Boston, October 3-5, 2012.
Since conceiving and founding the Consumer Genetics Conference in 2008, Boyce and Salisbury have been responsible for organizing and running the groundbreaking meeting, which has regularly sold out attendance registrations in the 3 years since its inception. This annual conference has provided a unique forum to discuss best practices and current thinking on the technology, regulatory, business and application issues in this rapidly changing field at the intersection of genetics, medicine and consumer products.
In continuing the events tradition, the 2012 program will again feature compelling presentations and energetic panel discussions from a wide range of thought leaders representing diverse perspectives. As the current program comes together, regular updates of the conference agenda and additional details will be available on the conference website, http://www.ConsumerGeneticsConference.com.
The Consumer Genetics Conference (CGC) was founded on the premise of serving as an open forum for all opinions to be voiced across the fields of science, medicine, law, and ethics on the subject of consumer genetics. This open format has driven significant growth in the number of attendees over the years reaching a threshold at which the conference needs to be more efficiently managed. The founders of the Consumer Genetics Conference are delighted to have partnered with Cambridge Healthtech Institute, a company with a deep understanding of issues within life sciences, as a strategic partner in order to help guide the conference in this critical stage of growth, said Boyce.
I am delighted that CHI will be working closely with John and Meredith within this strategic alliance. We have kept a close eye on this very successful event, and a number of us from CHI have attended each of the first three years, said CHI President Phillips Kuhl. The focus of this meeting represents an excellent complement to many topics where CHI is already running many successful conferences, ranging from next-gen sequencing and molecular diagnostics to clinical genomics. The inclusion of non-medical consumer applications represents an important and fascinating broadening of the scope of topic coverage for us.
There are a lot of meetings focused on the science of personalized medicine, but the Consumer Genetics Conference is the only event that looks at the full spectrum from academia to large consumer companies and helps attendees understand how to start and run a business in this dynamic field, said Salisbury. Our goal for this meeting has been and continues to be about advancing the discussion and making sure that all stakeholders have a voice in establishing best practices for putting genetic information in the hands of consumers.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business executives from top pharmaceutical, biotech and technology companies, as well as academic and other not-for profit organizations. Each year CHI organizes more than 150 different conference programs and tracks, as well as numerous additional educational short courses and webinars across applied scientific and technical topics. In addition to CHI Conferences, the companys portfolio of products and services also include Barnett International (http://www.barnettinternational.com) clinical training and publications, news and conferences from Bio-IT World (http://www.bio-itworld.com), market research reports from Insight Pharma Reports (http://www.insightpharmareports.com), and commercialization consulting from Cambridge Healthtech Associates (http://www.chacorporate.com).
Founded in 1992, Cambridge Healthtech Institute recently celebrated 20 years of serving the life sciences industry. The company strives to develop high quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest applied developments. This information is made available in a variety of formats, including live and on-line events, printed and electronic reports and other publications, as well as consulting and lead generation services. CHI has developed an excellent reputation for understanding key trends driving technological and business changes throughout the industry
About the Consumer Genetics Council
The Consumer Genetics Council is an organization that aims to serve as an advisory board for consumer genetics. Co-founded by John Boyce, president and CEO of GnuBio (http://www.gnubio.com) and Principal of Delphi Bio (http://www.delphibio.com), and Meredith Salisbury, senior consultant with Bioscribe (http://www.bioscribe.com), the Council will advise on the Consumer Genetics Conference as well as for companies and other entities looking to ensure the use of best practices in the consumer genetics space.
For Cambridge Healthtech Institute, please contact: Lisa Scimemi (lscimemi(at)healthtech(dot)com), T-781-972-5446
For Consumer Genetics Council, please contact: Lynn Blenkhorn, T-508-851-0930